Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Muxiang Weitai Dripping Pills
- Development stage
- Unknown
- Lead developer
- Tianjin Danxi Chinese Medicine Research Institute
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Muxiang Weitai Dripping Pills is a Traditional Chinese Medicine (TCM) candidate developed by the Tianjin Danxi Chinese Medicine Research Institute for the treatment of functional dyspepsia, specifically targeting the spleen deficiency and qi stagnation syndrome. The formulation utilizes dripping pill technology, a solid dispersion method that enhances the solubility and bioavailability of active herbal extracts. The primary active component, Muxiang (Aucklandia lappa), is traditionally recognized for its prokinetic and analgesic properties in the gastrointestinal tract. The drug is intended to improve gastric motility and alleviate common symptoms of dyspepsia, such as postprandial fullness, early satiety, and epigastric pain. It has undergone Phase 2 clinical evaluation in China to assess its efficacy and safety profile.
- Brand names
- Muxiang Weitai Dripping Pills
- Other names
- Muxiang Weitai Diwan木香微泰滴丸
Beyond the preview
Go deeper on Muxiang Weitai Dripping Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Muxiang Weitai Dripping Pills.